E-mail not displaying correctly? View it in your browser.
Upgrade Your Cell-Based Assays to 3D
Our Products
& Services

Click to find
more about our
 





Invitation to InSphero workshop “Compound de-risking with 3D-cell-culture systems” – Feb 2012 in Copenhagen, DK

Meet InSphero at SLAS 2012 - Feb 4-8 in San Diego, CA, USA

Participate at DECHEMA 3D Cell Culture symposium - March 14-16, 2012 in Zurich, Switzerland


An Integrated Platform Solution for Microtissue Culture and Assay - GravityPlus™ and GravityTRAP™ – A Perfect Match!
With GravityTRAP™ InSphero introduces the first commercially available microtiter plate format for maintaining and assaying scaffold-free 3-dimensional cell cultures. The plate assures straightforward and safe handling of microtissues comparable to standard procedures with 2D cell culture. This new plate format opens a completely new range of applications in a field where improved biological in vitro systems are in great demand.










Click to find more information in InSphero White Paper.

Special Offer: Introductory trial of the GravityPLUS™ platform at USD 195
Offer expires on Dec 31, 2011

Now there is an easy way to get firsthand experience of InSphero's patent-pending hanging-drop technology platform. Our offer provides a low cost opportunity to evaluate the handling, instrument compatibility and robustness of our GravityPLUS hanging-drop system. In addition, you receive the new GravityTRAP plates, which allow high-resolution microscopy, long-term incubation and assays in a well-known format. Take advantage of this exceptional 75% discount offer and gain your first experience of 3D microtissue technology for only USD 195 plus shipping. Credit-card payment available. Kit contents: 3 GravityPLUS plates with humidity control, 3 GravityTRAP plates for microtissue transfer, assays and inspection, instructions.

Contact our sales team now : sales@insphero.com

Invitation to InSphero workshop “Compound de-risking with 3D-cell-culture systems” – Feb 2012 in Copenhagen, DK
Become fully acquainted with the technical and cost issues involved in the implementation of 3D in vitro models for high-throughput toxicological and efficacy studies by attending an InSphero workshop. A hands-on session with InSphero's automation compatible GravityPLUS system is included in the program. The next full-day workshop will take place in

- Copenhagen, DK, in February 2012.

Workshop date, program details and registration information will be available soon on our website or can be requested here.

Meet InSphero at SLAS 2012 - Feb 4-8 in San Diego, CA, USA
Meet the InSphero team at SLAS 1st Annual Conference & Exhibition to learn how scaffold-free organotypic 3D microtissues, and 3D optimized assays, are boosting the process of drug discovery and development.
To arrange a meeting or a webinar please send us an E-mail.

Participate at DECHEMA 3D Cell Culture symposium - March 14-16, 2012 in Zurich, Switzerland
InSphero is supporting this 2.5-day symposium covering the latest developments in 3D-cell-culture technology. More information on registration and exhibiting can be found on the official symposium website. If you would like to meet InSphero or visit our labs during this event, please let us know in advance.
About InSphero
 

InSphero is a leading supplier of organotypic, biological in-vitro 3D microtissues for highly predictive drug testing. The company, headquartered in Zurich, Switzerland, currently counts 6 of the top ten global pharmaceutical and cosmetics companies as customers, and is helping them implement the company’s patent-pending microtissue technology in their development work-flow. InSphero’s 3D microtissues are scaffold free, highly reproducible and delivered in an automation-compatible 96-well format to replace conventional 2D cell assays for better biological relevance and predictivity. The 3D cancer microtissues reflect tumor physiology and are used routinely for screening. For toxicology and metabolics applications, rat and human 3D liver microtissues predict even rare cases of idiosyncratic toxicology and remain viable for more than 5 weeks for chronic studies. InSphero’s off-the-shelf portfolio of assay-ready microtissues is complemented by custom-made 3D microtissues with a development time of 4-6 weeks and production turnaround of less than 10 days.
InSphero is a spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich. The company was recognized for its scientific and commercial achievements with a number of awards, including the VentureKick award, Heuberger Entrepreneurial Award, CTIstartup certification and the SLAS New Product Award (NPA) 2011 Designation.


Our mailing address is:
InSphero
Wagistrasse 27
Schlieren, 8952


Copyright (C) 2011 InSphero All rights reserved.